Insect gene expression responds to dietMay 07, 2009Cabbage looper caterpillars (Trichoplusia ni) are able to alter the expression of genes associated with metabolism, homeostasis and immunity in response to feeding on plants carrying bacteria. Research published in BioMed Central's open access journal Frontiers in Zoology has shown that, as well as tailoring gene expression within their own digestive systems, the insects are able to pass this information along to their offspring. Dalial Freitak worked with a team of researchers at the Max Planck Institute for Chemical Ecology to study the effects of dietary bacteria on general gene expression in the plant pest. She said, "Larval feeding on a bacteria-rich diet leads to substantial gene expression changes, potentially resulting in a reorganization of the insects' metabolism to maintain organismal homeostasis, not only in the larval but also in the adult stage." The authors believe that having a suite of genes capable of responding to dietary composition allows the cabbage looper to fine-tune its natural defenses. Freitak said, "Mounting an immune response is costly and dangerous. The fact the insects can up regulate immunity related genes like Gloverin, HDD1 and hemolin in response to the presence of bacteria, but leave them switched off in the absence of pathogens, minimizes the release of multiple potentially cytotoxic molecules, which could in turn activate other stress related defenses". The researchers also found that the eggs of parents fed on a bacterial diet showed different gene expression patterns to eggs from parents who had sterile food. They conclude, "If expression differences in eggs carry over into the larvae that develop from them, this would support the idea that parents are able to prime their offspring against possible environmental stressors, like increased microbial exposure". BioMed Central |
|||||||||||||||||||||
| Related Gene Expression Current Events and Gene Expression News Articles New research into the mechanisms of gene regulation A team led by Penn State's Ross Hardison, T. Ming Chu Professor of Biochemistry and Molecular Biology, has taken a large step toward unraveling how regulatory proteins control the production of gene products during development and growth. The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. Study reveals why certain drug combinations backfire Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow. Penn Study Provides First Clear Idea of How Rare Bone Disease Progresses An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton. Why can't chimps speak? If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not? Treatment to improve degenerating muscle gains strength A study appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with certain degenerative muscle disorders. BUSM researchers show dieters can experience neurobiological similarities of drug addicts Researchers from Boston University School of Medicine (BUSM) have shown that intermittent access to foods rich in fat and sugar induces changes in the brain which are comparable to those observed in drug dependence. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Deciphering the regulatory code Embryonic development is like a well-organised building project, with the embryo's DNA serving as the blueprint from which all construction details are derived. Experimental agent reduces breast cancer metastasis to bone Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer. More Gene Expression Current Events and Gene Expression News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||